Vagus Nerve Stimulators: Medical Devices Pipeline Assessment 2016
Vagus Nerve Stimulators Medical Devices Pipeline Assessment, 2016
PUNE, INDIA, November 16, 2016 /EINPresswire.com/ -- The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators1 pipeline products.Get Sample Report @ https://www.wiseguyreports.com/sample-request/729489-vagus-nerve-stimulators-medical-devices-pipeline-assessment-2016
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
Scope
- Extensive coverage of the Vagus Nerve Stimulators under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vagus Nerve Stimulators and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vagus Nerve Stimulators under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vagus Nerve Stimulators Overview 7
3 Products under Development 8
3.1 Vagus Nerve Stimulators - Pipeline Products by Stage of Development 8
3.2 Vagus Nerve Stimulators - Pipeline Products by Territory 9
3.3 Vagus Nerve Stimulators - Pipeline Products by Regulatory Path 10
3.4 Vagus Nerve Stimulators - Pipeline Products by Estimated Approval Date 11
3.5 Vagus Nerve Stimulators - Ongoing Clinical Trials 12
4 Vagus Nerve Stimulators - Pipeline Products under Development by Companies 13
4.1 Vagus Nerve Stimulators Companies - Pipeline Products by Stage of Development 13
4.2 Vagus Nerve Stimulators - Pipeline Products by Stage of Development 14
5 Vagus Nerve Stimulators Companies and Product Overview 15
5.1 BioControl Medical Company Overview 15
5.1.1 BioControl Medical Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Boston Scientific Corporation Company Overview 17
5.2.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 CerboMed GmbH Company Overview 21
5.3.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Cerebral RX Ltd. Company Overview 22
5.4.1 Cerebral RX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Cyberonics, Inc. Company Overview 23
5.5.1 Cyberonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 DuoCure Ltd. Company Overview 27
5.6.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 ElectroCore, LLC Company Overview 28
5.7.1 ElectroCore, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 LivaNova PLC Company Overview 34
5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.9 Medical University of South Carolina Company Overview 40
5.9.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 MicroTransponder Inc. Company Overview 42
5.10.1 MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Neurostream Technologies G.P. (Inactive) Company Overview 49
5.11.1 Neurostream Technologies G.P. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Purdue University Company Overview 51
5.12.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 Setpoint Medical Corp Company Overview 52
5.13.1 Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Trifectas Medical Corp. Company Overview 56
5.14.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 56
6 Vagus Nerve Stimulators- Recent Developments 57
6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 57
6.2 Oct 19, 2016: SetPoint Medical Presents Positive Clinical Results in Crohn’s Disease 58
Access Report @ https://www.wiseguyreports.com/reports/729489-vagus-nerve-stimulators-medical-devices-pipeline-assessment-2016
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here
1 https://www.wiseguyreports.com/sample-request/729489-vagus-nerve-stimulators-medical-devices-pipeline-assessment-2016